The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $3.60

Today's change+0.05 +1.41%
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $3.60

Today's change+0.05 +1.41%
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.

aTyr Pharma Inc up (U.S.)$0.05

aTyr Pharma Inc closed up Friday by (U.S.)$0.05 or 1.41% to (U.S.)$3.60. Over the last five days, shares have gained 18.03%, but are down 63.38% for the last year to date. Shares have underperformed the S&P 500 by 63.47% during the last year.

Key company metrics

  • Open(U.S.) $3.60
  • Previous close(U.S.) $3.55
  • High(U.S.) $3.69
  • Low(U.S.) $3.50
  • Bid / Ask(U.S.) $3.05 / (U.S.) $3.75
  • YTD % change-63.38%
  • Volume141,687
  • Average volume (10-day)70,472
  • Average volume (1-month)118,479
  • Average volume (3-month)146,181
  • 52-week range(U.S.) $2.48 to (U.S.) $10.93
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.61
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense14151616
Selling / general / administrative3444
Research & development10111213
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income-14-15-16-16
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-14-15-16-16
Income after tax-14-15-16-16
Income tax, total--------
Net income-14-15-16-16
Total adjustments to net income00--0
Net income before extra. items-14-15-16-16
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-14-15-16-16
Inc. avail. to common incl. extra. items-14-15-16-16
Diluted net income-14-15-16-16
Dilution adjustment--------
Diluted weighted average shares24242424
Diluted EPS excluding extraordinary itemsvalue per share-0.58-0.65-0.68-0.69
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.58-0.65-0.68-0.70